Pharmaceutical Contract Sales Outsourcing Market Size, Growth, Trends, Forecast 2021-2030

The global pharmaceutical contract sales outsourcing market size was valued at USD 7.1 billion in 2020 and is expected to reach USD 14.5 billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.

The global pharmaceutical contract sales outsourcing market size was valued at USD 7.1 billion in 2020 and is expected to reach USD 14.5 billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.

Pharmaceutical Contract Sales Outsourcing Market Size 2021 to 2030

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38524

Increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations, as it offers cost controls, better results, and flexibility in terms of operations is anticipated to drive the global pharmaceutical contract sales outsourcing (CSO) market.

Digitalization of Services Provided by CSOs to Propel Market

Improved and advanced services provided by CSOs such as in the field of non-personal promotions are anticipated to drive the global market during the forecast period. Large as well as small pharmaceutical companies are looking for drugs to cost effectively and quickly enter their pipelines and CSOs play an important role in this endeavor.

The rise in virtual detailing in outsourcing services is increasing dependence on CSO services. The surge in the usage of teledetailng propels the non-personal promotion of outsourcing. These advanced functions, including sales force and customer support are well-established in a CSO, and hence, can help the brand to get market recognition faster.

Key Segments

In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others. The personal promotion segment has been split into promotional sales team, key account management, and vacancy management. The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others

Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others.

Base on region, the North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period. Well-established healthcare, early adoption of technologically advanced services, and increase in acceptance & demand for pharmaceutical contract sales outsourcing services are the major factors likely to drive the market in the region during the forecast period

The market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2030.

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global pharmaceutical contract sales outsourcing market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the pharmaceutical contract sales outsourcing market.

The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.

Competitive Landscape and Market Share Analysis

The pharmaceutical contract sales outsourcing market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, pharmaceutical contract sales outsourcing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the pharmaceutical contract sales outsourcing sales, revenue and market share for each player covered in this report.

  • Crucial data regarding the major contenders, product portfolio, market remuneration, and production patterns are documented in the report.
  • The report presents the pricing models followed by each company, alongside the gross margins and market share held by each company.

Key Players

The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market: Segmentation

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Service

  • Personal Promotion
      • Promotional Sales Team
        • Dedicated Sales Team
        • Syndicated Sales Team
      • Key Account Management
      • Vacancy Management
  • Non-personal Promotion
      • Tele-detailing
      • Interactive E-detailing
      • Customer Service
      • Medical Science Liaisons
      • Patient Engagement Services
      • Others (telesampling)
  • Others (Field Management/Reporting and Sales Training)

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Therapeutic Area

    • Cardiovascular Disorders
    • Oncology
    • Metabolic Disorders
    • Neurology
    • Orthopedic Diseases
    • Infectious Diseases
    • Others

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38524

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333